Rossi Antonio - U.O. Oncologia Medica, Azienda Ospedaliera S.G. Moscati, Avellino, Italy. arossi_it@yahoo.it

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 10 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Cisplatin versus carboplatin-based regimens in the treatment of small cell lung cancer (SCLC): meta-analysis of published randomized clinical trials (RCTs)

Antonio Rossi,Massimo Di Maio,Olga Martelli,Marina C. Garassino,Paolo Maione,Cesare Gridelli

JOURNAL OF THORACIC ONCOLOGY（2009）

引用0浏览0引用

Safety profile of erlotinib in patients with advanced non-small cell lung cancer with chronic renal failure

Cesare Gridelli,Paolo Maione,Domenico Galetta,Antonio Rossi

Journal of Thoracic Oncology（2007）

引用7浏览0WOS引用

Safety profile of platinum-based chemotherapy in the treatment of advanced non-small cell lung cancer in elderly patients

Antonio Rossi, Paolo Maione,Cesare Gridelli

Expert opinion on drug safety（2005）

引用11浏览0WOS引用

Single-agent pemetrexed or sequentially administered pemetrexed/gemcitabine as first-line chemotherapy for advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy: Preliminary results of a phase II randomized trial

Cesare Gridelli,Martin Reck,V. Gregorc,Maria Rita Migliorino, Thomas Müller,Christian Manegold,Adolfo Favaretto, E. Crucitta,Antonio Rossi,G. Koschel

ANNALS OF ONCOLOGY（2005）

引用0浏览0引用

Phase II randomized trial of pemetrexed or sequentially-administered pemetrexed/gemcitabine for untreated advanced non-small cell lung cancer (NSCLC) in elderly or PS2 patients

C. Gridelli,M. Reck,V. Gregorc,M. Migliorino, T. R. Muller,C. Manegold,A. Favaretto,E. Crucitta, M. Munoz, L. Cirri, L. Marini,A. Rossi,

ANNALS OF ONCOLOGYno. SUPnan (2005): 28-29

引用0浏览0引用

Single-agent gefitinib in advanced non-small-cell lung cancer elderly patients unsuitable for chemotherapy: Experience in two patients with chronic renal failure

A. Rossi,P. Maione,C. Guerriero,G. Colantuoni,F. Del Gaizo,D. Nicolella,C. Ferrara,C. Gridelli

ANNALS OF ONCOLOGYno. SUPnan (2005): 164-164

引用0浏览0引用

P-488 Phase II randomized trial of single-agent pemetrexed orsequentially administered pemetrexed/gemcitabine as front-line chemotherapy for the treatment of advanced non-small cell lung cancer (NSCLC) in elderly patients or patients ineligible for platinum-based chemotherapy

Cesare Gridelli, Martin Reck,Vanessa Gregorc,Maria Rita Migliorino, Thomas Muller,Ch Manegold,Adolfo Favaretto,Alexander Schmittel,Orazio Caffo, J Blatter,M Martinez Munoz, E Crucitta,

LUNG CANCER（2005）

引用0浏览0引用

The role of targeted therapy in non-small cell lung cancer

Paolo Maione,Antonio Rossi,Giuseppe Airoma,Carmine Ferrara,Vincenzo Castaldo,Cesare Gridelli

Critical Reviews in Oncology/Hematology（2004）

引用23浏览0WOS引用

Corticosteroids Underemployment In Delayed Chemotherapy-Induced Nausea And Emesis With Poor Adherence To American Society Of Clinical Oncology Guidelines: Is This A Reasonable Clinical Choice For The Elderly

Cesare Gridelli,Paolo Maione,Antonio Rossi

JOURNAL OF CLINICAL ONCOLOGY（2003）

引用10浏览0WOS引用

First line chemotherapy with bolus 5-FU and folinic acid plus oxaliplatin in advanced colorectal cancer: Preliminary data of a phase II trial

A Ravaioli,D Amadori,G Cruciani,L Frassineti,M Marangolo,I Panzini,E Pasquini,A Rossi,D Turci,D Tassinari

ANNALS OF ONCOLOGYno. SUPnan (2000): 50-50

引用0浏览0引用

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn